IN2015DN03076A - - Google Patents

Download PDF

Info

Publication number
IN2015DN03076A
IN2015DN03076A IN3076DEN2015A IN2015DN03076A IN 2015DN03076 A IN2015DN03076 A IN 2015DN03076A IN 3076DEN2015 A IN3076DEN2015 A IN 3076DEN2015A IN 2015DN03076 A IN2015DN03076 A IN 2015DN03076A
Authority
IN
India
Prior art keywords
immimogenicity
rabv
tiine
reproducible
protein
Prior art date
Application number
Other languages
English (en)
Inventor
Todd Gareth Smith
Charles Rupprecht
Original Assignee
Government Of The Us Zw Secretary Of The Dept Of Health And Human Services Ct S For Disease Control
Todd Gareth Smith
Charles Rupprecht
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Government Of The Us Zw Secretary Of The Dept Of Health And Human Services Ct S For Disease Control, Todd Gareth Smith, Charles Rupprecht filed Critical Government Of The Us Zw Secretary Of The Dept Of Health And Human Services Ct S For Disease Control
Publication of IN2015DN03076A publication Critical patent/IN2015DN03076A/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/205Rhabdoviridae, e.g. rabies virus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/20011Rhabdoviridae
    • C12N2760/20111Lyssavirus, e.g. rabies virus
    • C12N2760/20122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/20011Rhabdoviridae
    • C12N2760/20111Lyssavirus, e.g. rabies virus
    • C12N2760/20134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/145Rhabdoviridae, e.g. rabies virus, Duvenhage virus, Mokola virus or vesicular stomatitis virus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4728Details alpha-Glycoproteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
IN3076DEN2015 2012-10-12 2013-10-15 IN2015DN03076A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261713130P 2012-10-12 2012-10-12
PCT/US2013/064911 WO2014059434A1 (en) 2012-10-12 2013-10-15 Assay for analyses of rabies virus glycoprotein

Publications (1)

Publication Number Publication Date
IN2015DN03076A true IN2015DN03076A (pt) 2015-10-02

Family

ID=50477987

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3076DEN2015 IN2015DN03076A (pt) 2012-10-12 2013-10-15

Country Status (3)

Country Link
US (1) US20150276738A1 (pt)
IN (1) IN2015DN03076A (pt)
WO (1) WO2014059434A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104076146A (zh) * 2014-06-19 2014-10-01 华北制药集团新药研究开发有限责任公司 一种检测人抗狂犬病毒抗体的elisa试剂盒
CN111979120B (zh) * 2019-05-23 2022-09-27 比欧联科供应链管理(北京)有限公司 一种狂犬疫苗核酸消化去除装置及实验方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2406629B9 (en) * 2009-03-13 2014-03-26 Allergan, Inc. Immuno-based retargeted endopeptidase activity assays
WO2011080765A2 (en) * 2010-01-04 2011-07-07 Indian Immunologicals Limited Recombinant human bivalent diabody against rabies virus and uses thereof

Also Published As

Publication number Publication date
WO2014059434A1 (en) 2014-04-17
US20150276738A1 (en) 2015-10-01

Similar Documents

Publication Publication Date Title
HUS2100021I1 (hu) PCSK9 iRNS készítmények és eljárások azok alkalmazására
EP3862439A3 (en) Liver cancer detection kit or device, and detection method
BR112017001579A2 (pt) anticorpos anti-cd3, anticorpos anti-cd3 ativáveis, anticorpos anti-cd3 multiespecíficos, anticorpos anti-cd3 ativáveis multiespecíficos e métodos de uso dos mesmos
TWD178953S (zh) 混合容器
PH12015500196B1 (en) Methods of treating a tauopathy
BR112017009764A2 (pt) anticorpos biespecíficos e métodos de uso em oftalmologia
HK1252967A1 (zh) 治疗性hpv18疫苗
PT3406633T (pt) Anticorpos multi-específicos, anticorpos ativáveis multi-específicos e métodos de utilização dos mesmos
EP4495266A3 (en) Esophageal cancer detection kit or device, and detection method
TWD174962S (zh) 攪拌容器之部分
CA152180S (en) Analytical apparatus for drug testing
Drygaś et al. Distributivity equations in the class of semi-t-operators
MX2019015604A (es) Anticuerpos anti-tau y usos de los mismos en el tratamiento de una tauopatia.
PH12016500753B1 (en) Antibodies specific to fcrn
WO2013186639A3 (en) Methylation biomarkers for breast cancer
Hasebe et al. Stress analysis of quasi-orthotropic elastic plane
EP4461219A3 (en) Analyte level calibration using baseline analyte level
TWD166713S (zh) 用於基板托盤的封接件
Abraham et al. Studies on the hydrogen bond acidity, and other descriptors and properties for hydroxyflavones and hydroxyisoflavones
TR201902547T4 (tr) Oksi̇dati̇f stresli̇ hastalarda parati̇roi̇d hormonunun ölçüm araçlari ve yöntemleri̇
MY181007A (en) Scale drop disease (sdd) causative virus and derivatives thereof
EP3082863A4 (en) Alpha-enolase specific antibodies and method of use in immune diseases
IN2015DN03076A (pt)
EA201691091A1 (ru) Диагностические реагенты для улучшенной in vivo или in vitro клеточно-опосредованной иммунологической диагностики туберкулеза
EP2959296A4 (en) ELECTROCHEMILUMINESCENCE (ECL) DETECTION REAGENTS AND METHOD FOR MEASURING ENZYME ACTIVITY